Research shows that infections, particularly viruses like COVID-19, HIV, and hepatitis C, appear to trigger or worsen vitiligo by disrupting the immune system and causing it to attack pigment-producing skin cells. According to Gram Research analysis of studies from 2010 to 2023, bacterial infections like Helicobacter pylori and vitamin D deficiency may also contribute to vitiligo development. While the exact mechanisms remain complex, treating infections promptly and maintaining adequate vitamin D levels may help prevent vitiligo flare-ups in susceptible individuals.
Researchers reviewed studies from 2010 to 2023 to understand whether infections might cause or worsen vitiligo, a skin condition that causes white patches. According to Gram Research analysis, several types of infections including viruses like COVID-19, bacteria, and fungi appear to play a role in vitiligo development. The review found that infections may trigger the immune system to attack skin cells that produce color, leading to white patches. While the exact mechanisms remain complex, this research suggests that treating infections and maintaining vitamin D levels could potentially help manage vitiligo better.
Key Statistics
A 2023 systematic review of studies from 2010 to June 2023 found that viral infections including HIV, varicella-zoster virus, hepatitis C, and SARS-CoV-2 are associated with vitiligo development through immune system dysregulation and cytokine imbalances.
Research reviewed by Gram identified that COVID-19 can trigger vitiligo by disrupting CD8+ lymphocytes and activating proinflammatory cytokines, with some cases showing bystander activation where immune cells attack melanocytes.
A systematic review of vitiligo and infections found that Helicobacter pylori bacterial infection, fungal infections, and vitamin D deficiency may contribute to vitiligo pathogenesis by altering cellular immunity and increasing systemic inflammation.
The 2023 systematic review identified that multiple infection types and vitamin D deficiency work together as potential triggers for vitiligo, suggesting that comprehensive infection treatment and vitamin D management may help manage this skin condition.
The Quick Take
- What they studied: Whether viral, bacterial, fungal, and parasitic infections are connected to the development or worsening of vitiligo, a skin condition that causes loss of skin color
- Who participated: This was a systematic review that analyzed published research studies from 2010 through June 2023 rather than studying individual patients directly
- Key finding: Multiple types of infections, particularly viruses like HIV, chickenpox virus, hepatitis C, and COVID-19, appear to trigger or worsen vitiligo by disrupting the immune system and causing it to attack pigment-producing skin cells
- What it means for you: If you have vitiligo, treating infections promptly and maintaining healthy vitamin D levels may help prevent flare-ups. However, this research is still emerging, and you should work with a dermatologist to develop a personalized treatment plan
The Research Details
Researchers conducted a systematic review, which means they searched multiple scientific databases (PubMed, Scopus, and Web of Science) for all published studies examining the link between infections and vitiligo from 2010 to June 2023. They followed strict guidelines called PRISMA to ensure they reviewed studies fairly and consistently. Rather than conducting their own experiments, they analyzed and summarized findings from existing research to identify patterns and connections between different types of infections and vitiligo development.
This approach is valuable because it combines evidence from many different studies, giving a broader picture than any single study could provide. By reviewing hundreds of research papers, scientists can identify common themes and determine which infections have the strongest evidence linking them to vitiligo.
Understanding whether infections cause vitiligo is important because vitiligo affects millions of people worldwide and currently has no cure. If infections are a trigger, doctors could potentially prevent or reduce vitiligo by treating infections early and aggressively. This knowledge could also lead to new treatment strategies that target the immune system in specific ways. Additionally, people with vitiligo could take preventive steps like getting vaccinated against certain viruses or maintaining good infection prevention habits.
This systematic review followed established scientific standards (PRISMA guidelines) designed to minimize bias and ensure thorough research. The review examined studies published in peer-reviewed journals, which means other scientists have already reviewed the quality of those studies. However, readers should know that the review included studies with varying quality levels, and some findings are based on limited evidence. The researchers did not conduct a meta-analysis (statistical combination of results), so some conclusions are based on patterns observed across studies rather than precise numerical calculations.
What the Results Show
The review identified strong evidence that viral infections are associated with vitiligo development. Specifically, HIV, varicella-zoster virus (which causes chickenpox and shingles), and hepatitis C appear to trigger vitiligo through multiple mechanisms. When these viruses infect the body, they can cause the immune system to become dysregulated, meaning it doesn’t work properly. This dysregulation can lead the immune system to mistakenly attack melanocytes, the cells that produce skin pigment, resulting in the white patches characteristic of vitiligo.
COVID-19 emerged as a particularly important trigger in more recent studies. The virus can disrupt CD8+ lymphocytes, which are immune cells that normally help protect the body. When these cells malfunction, they may attack melanocytes. Additionally, the virus triggers the release of inflammatory chemicals called cytokines that can damage pigment-producing cells. Some research suggests that the immune system’s response to COVID-19 can cause “bystander activation,” where immune cells meant to fight the virus accidentally attack the body’s own melanocytes.
Bacterial infections also appear relevant to vitiligo. Helicobacter pylori, a bacterium that lives in the stomach, has been associated with vitiligo in multiple studies. Fungal and parasitic infections may also contribute by altering how the immune system functions and increasing inflammation throughout the body. Vitamin D deficiency frequently accompanies these infections and may worsen vitiligo by further impairing immune regulation.
The review identified several mechanisms explaining how infections trigger vitiligo. The Koebner phenomenon, where skin trauma or injury triggers new vitiligo patches, may be activated by infections. Infections can also activate a protein called MDA5, which plays a role in immune responses and may contribute to vitiligo development. Additionally, infections often cause vitamin D deficiency, which is important for immune system regulation. When vitamin D levels drop, the immune system becomes more likely to malfunction and attack the body’s own cells. The research suggests that multiple factors work together: an infection triggers immune dysregulation, vitamin D deficiency worsens this dysregulation, and the result is an attack on melanocytes.
This systematic review builds on decades of research suggesting that vitiligo has multiple causes rather than a single trigger. Previous theories focused on genetic factors, autoimmune mechanisms, and oxidative stress (cellular damage from unstable molecules). This review adds substantial evidence that infections are an important environmental trigger that can activate or worsen vitiligo in genetically susceptible people. The inclusion of COVID-19 studies represents new evidence not available in earlier reviews. The findings align with the emerging understanding that many autoimmune conditions, including vitiligo, result from a combination of genetic predisposition and environmental triggers like infections.
This systematic review has several important limitations. First, the researchers did not perform a meta-analysis, meaning they did not combine numerical results from multiple studies into one statistical calculation. This makes it harder to determine exactly how strong each association is. Second, many studies included in the review were observational, meaning they showed that infections and vitiligo occurred together but couldn’t prove that infections caused vitiligo. Third, the review included studies of varying quality, and some findings are based on small numbers of patients. Fourth, most research focused on specific populations in certain countries, so results may not apply equally to all ethnic groups or geographic regions. Finally, the mechanisms by which infections trigger vitiligo remain incompletely understood, and more research is needed to confirm the proposed explanations.
The Bottom Line
Based on this research, people with vitiligo should: (1) Treat infections promptly and completely, following medical advice for viral, bacterial, and fungal infections. (2) Maintain adequate vitamin D levels through sun exposure, diet, or supplements as recommended by a healthcare provider. (3) Consider discussing infection prevention strategies with their dermatologist, such as vaccinations when appropriate. (4) Monitor for vitiligo flare-ups following infections and report these patterns to their doctor. These recommendations have moderate confidence because the research shows associations between infections and vitiligo but doesn’t yet prove that treating infections will prevent vitiligo in all cases.
People with vitiligo should pay particular attention to this research, as should their healthcare providers. People with HIV, hepatitis C, or recent COVID-19 infections who are concerned about vitiligo development should discuss this with their doctors. Healthcare providers treating vitiligo patients should consider asking about recent infections and vitamin D status. People without vitiligo do not need to change their behavior based on this research, though maintaining good infection prevention practices and vitamin D levels supports overall health. Dermatologists and immunologists should use these findings to inform treatment strategies.
The timeline for seeing benefits from infection treatment or vitamin D supplementation varies. Some people may experience stabilization of vitiligo (stopping new patches from appearing) within weeks to months of treating an infection. However, repigmentation (return of skin color) typically takes months to years and is not guaranteed. Most experts recommend consistent management over at least 3 to 6 months before expecting significant improvement.
Frequently Asked Questions
Can COVID-19 cause vitiligo?
Research suggests COVID-19 can trigger or worsen vitiligo by disrupting immune cells and releasing inflammatory chemicals that attack pigment-producing skin cells. However, not everyone with COVID-19 develops vitiligo, indicating other factors like genetics also play a role.
Does treating infections help vitiligo?
While research shows infections are associated with vitiligo development, studies haven’t yet proven that treating infections will reverse existing vitiligo. However, treating infections promptly may help prevent new patches from appearing in susceptible people.
Is vitamin D deficiency related to vitiligo?
Yes, research indicates vitamin D deficiency frequently accompanies infections and may worsen vitiligo by impairing immune regulation. Maintaining adequate vitamin D levels through supplementation or sun exposure may help manage vitiligo, though more research is needed.
What types of infections trigger vitiligo?
Viral infections (HIV, chickenpox virus, hepatitis C, COVID-19), bacterial infections (Helicobacter pylori), and fungal infections have all been associated with vitiligo. Each type may trigger vitiligo through different immune system mechanisms.
Should I get vaccinated if I have vitiligo?
This research doesn’t address vaccination directly, but since infections are associated with vitiligo flare-ups, discussing vaccination with your dermatologist and primary care doctor is reasonable. They can weigh benefits and risks based on your individual situation.
Want to Apply This Research?
- Track infections and vitiligo flare-ups by logging the date, type of infection (viral, bacterial, fungal), symptoms, and any new or worsening vitiligo patches. Note vitamin D supplementation and sun exposure. Over time, patterns may emerge showing which infections correlate with vitiligo changes for your individual situation.
- Set reminders to maintain vitamin D levels through supplementation or sun exposure as recommended by your doctor. When you develop an infection, log it immediately and set a follow-up reminder to monitor for vitiligo changes over the next 2 to 4 weeks. Share this tracking data with your dermatologist at appointments to identify personal patterns.
- Create a monthly summary comparing infection frequency and severity with vitiligo activity. Track vitamin D levels if your doctor recommends testing. Over 6 to 12 months, review whether certain infections consistently precede vitiligo flare-ups. Use this personalized data to guide preventive strategies with your healthcare provider.
This article summarizes research on the association between infections and vitiligo but does not constitute medical advice. Vitiligo is a complex condition with multiple contributing factors, and the relationship between infections and vitiligo development remains an active area of research. Individual responses to infections and treatments vary significantly. If you have vitiligo or suspect you may develop it, consult a dermatologist or healthcare provider for personalized diagnosis, treatment recommendations, and management strategies. Do not start, stop, or change any medical treatments based solely on this article. This research identifies associations and potential mechanisms but does not prove that infections cause vitiligo in all cases.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.